Gene interactions and pathways from curated databases and text-mining

◀ Back to PRKACB

GSK3B — PRKACB

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Luo et al., J Alzheimers Dis 2004 : Independent of these effects, inhibition of PKA by H89 ( 10 uM ) significantly blocked TRH inhibition of GSK-3 beta
Jensen et al., Cell Signal 2007 : The PKA inhibitor H89 ( 50 microM ) reduced adrenaline stimulated GSK-3beta Ser9 phosphorylation but did not influence the effects of insulin
O'Driscoll et al., J Neurochem 2007 : The effects of bFGF on GSK3beta were dependent on protein kinase A (PKA) activation, as inhibition of this pathway blocked inactivation
Torii et al., Cell Signal 2008 : Based on another finding indicating that Wnt5a upregulated PKA mediated phosphorylation of glycogen synthase kinase-3beta ( GSK-3beta ) at serine 9 that caused inactivation of GSK-3beta and subsequently resulted in activation of the beta-catenin pathway, we have speculated that the Wnt5a anti-apoptotic activity may be partially mediated by PKA mediated phosphorylation of GSK-3beta and subsequent activation of the beta-catenin pathway
Hayashi et al., Thromb Haemost 2009 : These results suggested that cAMP elevating agents have two effects on PI3K signalling : inhibition of Akt phosphorylation independent of PKA ; and stimulation of GSK-3beta phosphorylation dependent on PKA